Mascoma Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.6K Sell
2,829
-1,683
-37% -$40.8K 0.02% 160
2025
Q1
$114K Buy
4,512
+8
+0.2% +$203 0.03% 124
2024
Q4
$119K Sell
4,504
-558
-11% -$14.8K 0.03% 126
2024
Q3
$146K Sell
5,062
-583
-10% -$16.9K 0.04% 110
2024
Q2
$158K Sell
5,645
-2,975
-35% -$83.2K 0.04% 106
2024
Q1
$239K Sell
8,620
-4,819
-36% -$134K 0.07% 89
2023
Q4
$387K Sell
13,439
-6,796
-34% -$196K 0.12% 66
2023
Q3
$671K Sell
20,235
-2,659
-12% -$88.2K 0.21% 48
2023
Q2
$816K Sell
22,894
-3,858
-14% -$138K 0.25% 48
2023
Q1
$1.04M Sell
26,752
-642
-2% -$25K 0.3% 44
2022
Q4
$1.4M Sell
27,394
-3,416
-11% -$175K 0.45% 40
2022
Q3
$1.35M Buy
30,810
+2,397
+8% +$105K 0.47% 40
2022
Q2
$1.49M Sell
28,413
-306
-1% -$16K 0.51% 38
2022
Q1
$1.49M Buy
28,719
+879
+3% +$45.5K 0.47% 43
2021
Q4
$1.64M Sell
27,840
-753
-3% -$44.5K 0.57% 38
2021
Q3
$1.23M Buy
28,593
+938
+3% +$40.4K 0.48% 37
2021
Q2
$1.08M Buy
27,655
+267
+1% +$10.5K 0.46% 42
2021
Q1
$992K Buy
27,388
+3,058
+13% +$111K 0.43% 40
2020
Q4
$896K Buy
+24,330
New +$896K 0.45% 40
2019
Q3
$294K Sell
8,639
-648
-7% -$22.1K 0.19% 59
2019
Q2
$382K Hold
9,287
0.24% 53
2019
Q1
$374K Sell
9,287
-1,143
-11% -$46K 0.25% 51
2018
Q4
$432K Sell
10,430
-3,051
-23% -$126K 0.33% 40
2018
Q3
$564K Buy
13,481
+106
+0.8% +$4.44K 0.37% 34
2018
Q2
$460K Buy
13,375
+865
+7% +$29.8K 0.32% 40
2018
Q1
$421K Sell
12,510
-696
-5% -$23.4K 0.28% 44
2017
Q4
$459K Sell
13,206
-2,918
-18% -$101K 0.28% 37
2017
Q3
$546K Buy
16,124
+103
+0.6% +$3.49K 0.36% 38
2017
Q2
$511K Sell
16,021
-1,266
-7% -$40.4K 0.34% 36
2017
Q1
$561K Sell
17,287
-873
-5% -$28.3K 0.4% 30
2016
Q4
$560K Buy
+18,160
New +$560K 0.41% 33